<DOC>
	<DOCNO>NCT02880111</DOCNO>
	<brief_summary>Rates DMBT1 ( Glycoprotein like ) Sputum CF Patients without may different accord Pseudomonas Aeruginosa chronic colonization status . The aim study compare rate DMBT1 ( Glycoprotein like ) Sputum CF patient without Pseudomonas Aeruginosa chronic colonization .</brief_summary>
	<brief_title>Rates DMBT1 ( Glycoprotein ) Sputum CF Patients With Pseudomonas Aeruginosa</brief_title>
	<detailed_description>Rates DMBT1 ( Deleted Malignant Brain Tumor 1 ) compare 2 group 30 CF patient : group 1 : Pseudomonas Aeruginosa chronic colonization group 2 30 CF patient without Pseudomonas Aeruginosa chronic colonization .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>CF patient 6 35 year Availability sputum Signed Informed consent Cardiac insufficiency Antiinflammatory drug go Oral corticosteroid therapy Inhaled corticosteroid two week inclusion , Patient await lung transplantation Patient past history heart/lung transplantation Patient sputum examination positive : atypical mycobacteria , Burkholderia cepacia , Stenotrophomonas maltophilia , Patient chronically colonize multiresistant Pseudomonas aeruginosa Inhaled Colymicine® Tobramycin® two week inclusion Change CF treatment last 4 week +/ 2 day inclusion : corticosteroid , pancreatic extract , antisecretory drug ...</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Malignant Brain Tumor</keyword>
	<keyword>patient sputum</keyword>
</DOC>